NATR (STOCKS)
Nature's Sunshine Products Inc.
$15.440000
-0.070000 (-0.45%)
Prev close: $15.510000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Kenneth G. Romanzi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $269.39M
- Employees
- 819
- P/E (TTM)
- 15.46
- P/B (TTM)
- 1.61
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $492.02M |
| Benefits Costs and Expenses | $463.34M |
| Cost Of Revenue | $132.04M |
| Costs And Expenses | $463.34M |
| Gross Profit | $359.98M |
| Operating Expenses | $330.66M |
| Selling, General, and Administrative Expenses | $182.56M |
| Other Operating Expenses | $146.20M |
| Operating Income/Loss | $29.32M |
| Income/Loss From Continuing Operations After Tax | $18.70M |
| Income/Loss From Continuing Operations Before Tax | $28.68M |
| Income Tax Expense/Benefit | $9.98M |
| Income Tax Expense/Benefit, Deferred | $1.55M |
| Net Income/Loss | $18.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $607.00K |
| Net Income/Loss Attributable To Parent | $18.10M |
| Net Income/Loss Available To Common Stockholders, Basic | $18.10M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.02 |
| Diluted Earnings Per Share | $1.01 |
| Basic Average Shares | 35,136,000 |
| Diluted Average Shares | 35,942,000 |
| Assets | $259.82M |
| Current Assets | $178.40M |
| Inventory | $71.73M |
| Other Current Assets | $106.67M |
| Noncurrent Assets | $81.43M |
| Fixed Assets | $30.96M |
| Other Non-current Assets | $50.47M |
| Liabilities | $90.51M |
| Current Liabilities | $68.75M |
| Accounts Payable | $7.73M |
| Other Current Liabilities | $61.02M |
| Noncurrent Liabilities | $21.76M |
| Equity | $169.32M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $169.32M |
| Liabilities And Equity | $259.82M |
| Net Cash Flow From Operating Activities | $27.36M |
| Net Cash Flow From Operating Activities, Continuing | $27.36M |
| Net Cash Flow From Investing Activities | -$9.28M |
| Net Cash Flow From Investing Activities, Continuing | -$9.28M |
| Net Cash Flow From Financing Activities | -$15.96M |
| Net Cash Flow From Financing Activities, Continuing | -$15.96M |
| Exchange Gains/Losses | -$972.00K |
| Net Cash Flow | $1.16M |
| Net Cash Flow, Continuing | $2.13M |
| Comprehensive Income/Loss | $16.12M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $930.00K |
| Comprehensive Income/Loss Attributable To Parent | $15.19M |
| Other Comprehensive Income/Loss | -$2.59M |